INARI MED INC's ticker is NARI and the CUSIP is 45332Y109. A total of 155 filers reported holding INARI MED INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,228,008 | +114.1% | 110,520 | +90.4% | 0.01% | +125.0% |
| Q2 2023 | $3,375,608 | +1.6% | 58,060 | +7.9% | 0.00% | 0.0% |
| Q1 2023 | $3,323,341 | +55.0% | 53,828 | +59.5% | 0.00% | +33.3% |
| Q4 2022 | $2,144,451 | +13.5% | 33,739 | +32.1% | 0.00% | +50.0% |
| Q3 2022 | $1,889,000 | -55.1% | 25,539 | -58.7% | 0.00% | -60.0% |
| Q2 2022 | $4,206,000 | -15.5% | 61,863 | +12.7% | 0.01% | 0.0% |
| Q1 2022 | $4,975,000 | +7.7% | 54,883 | +8.5% | 0.01% | +25.0% |
| Q4 2021 | $4,619,000 | +111.2% | 50,603 | +87.7% | 0.00% | +100.0% |
| Q3 2021 | $2,187,000 | +120.0% | 26,963 | +143.7% | 0.00% | +100.0% |
| Q2 2021 | $994,000 | -16.0% | 11,065 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $1,184,000 | -6.2% | 11,065 | -23.5% | 0.00% | -50.0% |
| Q4 2020 | $1,262,000 | +31.9% | 14,462 | +4.3% | 0.00% | +100.0% |
| Q3 2020 | $957,000 | +42.6% | 13,862 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $671,000 | – | 13,862 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darsana Capital Partners LP | 1,475,000 | $137,588,000 | 3.91% |
| Affinity Asset Advisors, LLC | 85,000 | $7,929,000 | 2.84% |
| Parian Global Management LP | 49,800 | $4,645,000 | 1.99% |
| AlpInvest Partners B.V. | 27,960 | $2,608,000 | 1.28% |
| Sio Capital Management, LLC | 46,332 | $4,322,000 | 1.07% |
| HARBOURVEST PARTNERS LLC | 88,598 | $8,264,000 | 0.79% |
| HAMILTON LANE ADVISORS LLC | 26,403 | $2,463,000 | 0.77% |
| Pier Capital, LLC | 76,708 | $7,155,000 | 0.72% |
| Lisanti Capital Growth, LLC | 46,035 | $4,294,000 | 0.53% |
| NEXT CENTURY GROWTH INVESTORS LLC | 66,822 | $6,233,000 | 0.49% |